Cleared Special

K111851 - MEDIOSTAR NEXT

K111851 is an FDA 510(k) clearance for MEDIOSTAR NEXT, manufactured by Asclepion Laser Technologies GmbH. The device is a Class 2 General & Plastic Surgery device with product code GEX cleared through the Special 510(k) pathway after a 9-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2011
Decision
9d
Days
Class 2
Risk

K111851 is an FDA 510(k) clearance for the MEDIOSTAR NEXT. Classified as Powered Laser Surgical Instrument within the GEX classification (a category for powered laser surgical instruments across multiple specialties), Class II - Special Controls.

Submitted by Asclepion Laser Technologies GmbH (Jena, Thuringia, DE). The FDA issued a Cleared decision on July 8, 2011 after a review of 9 days - a notably fast clearance cycle.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.4810 - the FDA general and plastic surgery device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Asclepion Laser Technologies GmbH devices

FDA 510(k) Submission Details - K111851

510(k) Number K111851 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 29, 2011
Decision Date July 08, 2011
Days to Decision 9 days
Submission Type Special
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
106d faster than avg
Panel avg: 115d · This submission: 9d
Pathway characteristics
Modification to existing cleared device.

GEX Device Classification - Class 2, Special Controls

Product Code GEX Powered Laser Surgical Instrument
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.4810
Definition A Laser (light Amplification By Stimulated Emission Of Radiation) Based Device Having Coherence, Collimated And Typically Monochromatic Radiation. Typically Indicated To To Cut, Destroy, Remove Or Coagulate Tissue, Generally Soft Tissue, For General Surgical Purpose In Medical Specialties Of General And Plastic Surgery, Dermatology/aesthetic, Podiatry, Otolaryngology (ent), Gynecology, Neurosurgery, Orthopedics (soft Tissue), Dental And Oral Surgery, And Dentistry. The Classification Regulation 21 Cfr 878.4810 Describes A Device That Is Carbon Dioxide Or Argon Laser Intended To Cut, Destroy, Remove Or Coagulate Tissue By The Light.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Peers - GEX Powered Laser Surgical Instrument

All 2215
Devices cleared under the same product code (GEX) and FDA review panel - the closest regulatory comparables to K111851.
YOULASER CO2 LASER SYSTEM
K111592 · Quanta System Spa · Aug 2011
VISION ONE LASER SYSTEM
K111213 · Lumenis, Inc. · Jul 2011
CANDELA GENTLELASE FAMILY OF LASERS
K111144 · Candela Corp. · Jul 2011
SP DYNAMIS, SP SPECTRO, XS DYNAMIS, XS SPECTRO, XP DYNAMIS, XP SPECTRO, MODELS M021-4AF/3, M002-2A
K101306 · Fotona D.D. · Jul 2011
CORTEX CO2 / ER:YAG LASER SYSTEM
K110897 · Sandstone Medical Technologies, LLC · Jul 2011
MEDART DIODE LASER SYSTEM & ACCESSORIES
K110243 · Medart A/S · Jun 2011